ARQT - Arcutis Biotherapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARQT is currently covered by 9 analysts with an average price target of $33.3. This is a potential upside of $15.73 (89.53%) from yesterday's end of day stock price of $17.57.

Arcutis Biotherapeutics 's activity chart (see below) currently has 61 price targets and 83 ratings on display. The stock rating distribution of ARQT is 17.95% HOLD and 82.05% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 23.17% with an average time for these price targets to be met of 64.6 days.

Highest price target for ARQT is $22, Lowest price target is $15, average price target is $17.57.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 07-Aug-2025. First documented stock forecast 25-Feb-2020.

Currently out of the existing stock ratings of ARQT, 7 are a HOLD (17.95%), 32 are a BUY (82.05%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$22

$4.62 (26.58%)

$20

1 months 19 days ago
(07-Aug-2025)

3/21 (14.29%)

$7.88 (55.81%)

275

Hold

$18

$0.62 (3.57%)

$6

2 months 1 days ago
(25-Jul-2025)

1/3 (33.33%)

$3.14 (21.13%)

108

Buy

$19

$1.62 (9.32%)

$19

5 months 23 days ago
(03-Apr-2025)

0/4 (0%)

$2.84 (17.57%)

Buy

5 months 23 days ago
(03-Apr-2025)

1/1 (100%)

$9.67 (36.73%)

27

Hold

$15

$-2.38 (-13.69%)

$11

6 months 30 days ago
(27-Feb-2025)

3/5 (60%)

$2.2 (17.19%)

41

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARQT (Arcutis Biotherapeutics ) average time for price targets to be met?

On average it took 64.6 days on average for the stock forecasts to be realized with a an average price target met ratio 23.17

Which analyst has the current highest performing score on ARQT (Arcutis Biotherapeutics ) with a proven track record?

GRAIG SUVANNAVEJH

Which analyst has the most public recommendations on ARQT (Arcutis Biotherapeutics )?

Graig Suvannavejh works at MIZUHO and has 3 price targets and 3 ratings on ARQT

Which analyst is the currently most bullish on ARQT (Arcutis Biotherapeutics )?

Graig Suvannavejh with highest potential upside - $36.28

Which analyst is the currently most reserved on ARQT (Arcutis Biotherapeutics )?

Nigel Dally with lowest potential downside - -$7.38

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?